Regulation of drug transporter expression by oncostatin M in human hepatocytes

Biochemical Pharmacology

Volumn 82, Issue 3, 2011, Pages 304-311

  Le Vee, Marc ^a   Jouan, Elodie ^a   Stieger, Bruno ^b   Lecureur, Valérie ^a   Fardel, Olivier ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Biliary elimination; Drug transporters; Human hepatocytes; Inflammation; Oncostatin M

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN P; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; ONCOSTATIN M; ONCOSTATIN M RECEPTOR; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B3; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; ORGANIC CATION TRANSPORTER 1; RECEPTOR SUBUNIT; SMALL INTERFERING RNA; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG CLEARANCE; DRUG TRANSPORT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL; LIVER CLEARANCE; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

C-REACTIVE PROTEIN; CARRIER PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; ONCOSTATIN M; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 79959556989     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.04.017     Document Type: Article

References (44)

1. M.J. Gomez-Lechon Oncostatin M signal transduction and biological activity Life Sci 65 20 1999 2019 2030 (Pubitemid 29524852)
2. M. Tanaka, and A. Miyajima Oncostatin M, a multifunctional cytokine Rev Physiol Biochem Pharmacol 149 2003 39 52
3. A. Kamiya, F.J. Gonzalez, and H. Nakauchi Identification and differentiation of hepatic stem cells during liver development Front Biosci 11 2006 1302 1310 (Pubitemid 43253423)
4. U. Dierssen, N. Beraza, H.H. Lutz, C. Liedtke, M. Ernst, and H.E. Wasmuth Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration J Biol Chem 283 15 2008 9886 9895
5. I. Znoyko, N. Sohara, S.S. Spicer, M. Trojanowska, and A. Reuben Expression of oncostatin M and its receptors in normal and cirrhotic human liver J Hepatol 43 5 2005 893 900 (Pubitemid 41414516)
6. K. Nakamura, H. Nonaka, H. Saito, M. Tanaka, and A. Miyajima Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice Hepatology 39 3 2004 635 644 (Pubitemid 38337643)
7. C.D. Richards, T.J. Brown, M. Shoyab, H. Baumann, and J. Gauldie Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro J Immunol 148 6 1992 1731 1736
8. A. Pardo-Saganta, M.U. Latasa, J. Castillo, L. Alvarez-Asiain, M.J. Perugorria, and P. Sarobe The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression J Hepatol 51 6 2009 1010 1020
9. Z. Abdel-Razzak, P. Loyer, A. Fautrel, J.C. Gautier, L. Corcos, and B. Turlin Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture Mol Pharmacol 44 4 1993 707 715 (Pubitemid 23317282)
10. E.T. Morgan, K.B. Goralski, M. Piquette-Miller, K.W. Renton, G.R. Robertson, and M.R. Chaluvadi Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer Drug Metab Dispos 36 2 2008 205 216 (Pubitemid 351185732)
11. M.I. Guillen, M.T. Donato, R. Jover, J.V. Castell, R. Fabra, and R. Trullenque Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes J Pharmacol Exp Ther 285 1 1998 127 134 (Pubitemid 28207577)
12. P. Chandra, and K.L. Brouwer The complexities of hepatic drug transport: current knowledge and emerging concepts Pharm Res 21 5 2004 719 735 (Pubitemid 39011292)
13. O. Fardel, L. Payen, A. Courtois, L. Vernhet, and V. Lecureur Regulation of biliary drug efflux pump expression by hormones and xenobiotics Toxicology 167 1 2001 37 46 (Pubitemid 32830945)
14. V. Petrovic, S. Teng, and M. Piquette-Miller Regulation of drug transporters during infection and inflammation Mol Interv 7 2 2007 99 111 (Pubitemid 46683180)
15. M. Le Vee, P. Gripon, B. Stieger, and O. Fardel Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta Drug Metab Dispos 36 2 2008 217 222 (Pubitemid 351185762)
16. O. Fardel, and M. Le Vee Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines Expert Opin Drug Metab Toxicol 5 12 2009 1469 1481
17. L. Diao, N. Li, T.G. Brayman, K.J. Hotz, and Y. Lai Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta} J Biol Chem 285 41 2010 31185 31192
18. E. Jigorel, M. Le Vee, C. Boursier-Neyret, M. Bertrand, and O. Fardel Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes Drug Metab Dispos 33 10 2005 1418 1422 (Pubitemid 41323987)
19. M. Le Vee, V. Lecureur, B. Stieger, and O. Fardel Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6 Drug Metab Dispos 37 3 2009 685 693
20. M. Le Vee, V. Lecureur, A. Moreau, B. Stieger, and O. Fardel Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes Drug Metab Dispos 37 11 2009 2228 2235
21. P. Gripon, S. Rumin, S. Urban, J. Le Seyec, D. Glaise, and I. Cannie Infection of a human hepatoma cell line by hepatitis B virus Proc Natl Acad Sci U S A 99 24 2002 15655 15660 (Pubitemid 35403987)
22. A. Guillouzo, A. Corlu, C. Aninat, D. Glaise, F. Morel, and C. Guguen-Guillouzo The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics Chem Biol Interact 168 1 2007 66 73 (Pubitemid 46659919)
23. M. Le Vee, E. Jouan, and O. Fardel Involvement of aryl hydrocarbon receptor in basal and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced expression of target genes in primary human hepatocytes Toxicol In Vitro 24 6 2010 1775 1781
24. E. Jigorel, M. Le Vee, C. Boursier-Neyret, Y. Parmentier, and O. Fardel Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes Drug Metab Dispos 34 10 2006 1756 1763 (Pubitemid 44427479)
25. R.D. Huber, B. Gao, M.A. Sidler Pfandler, W. Zhang-Fu, S. Leuthold, and B. Hagenbuch Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain Am J Physiol Cell Physiol 292 2 2007 C795 C806
26. B. Chung, F. Verdier, P. Matak, J.C. Deschemin, P. Mayeux, and S. Vaulont Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone FASEB J 24 6 2010 2093 2103
27. S. Vollmer, V. Kappler, J. Kaczor, D. Flugel, C. Rolvering, and N. Kato Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling Hepatology 50 1 2009 253 260
28. M. Le Vee, E. Jigorel, D. Glaise, P. Gripon, C. Guguen-Guillouzo, and O. Fardel Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line Eur J Pharm Sci 28 1-2 2006 109 117
29. M. Le Vee, E. Jouan, A. Moreau, and O. Fardel Regulation of drug transporter mRNA expression by interferon-gamma in primary human hepatocytes Fundam Clin Pharmacol 25 1 2011 99 103
30. V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, and G. Gstraunthaler Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol 293 5 2007 F1714 F1726
31. J.S. Silver, and C.A. Hunter gp130 at the nexus of inflammation, autoimmunity, and cancer J Leukoc Biol 88 6 2010 1145 1156
32. K. Nakashima, and T. Taga gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities Semin Hematol 35 3 1998 210 221 (Pubitemid 28337230)
33. Y. Yoshida, A. Kumar, Y. Koyama, H. Peng, A. Arman, and J.A. Boch Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism J Biol Chem 279 3 2004 1768 1776 (Pubitemid 38084444)
34. W. Yue, K. Abe, and K.L. Brouwer Knocking down breast cancer resistance protein (ABCG2) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of ABCG2 to drug biliary excretion Mol Pharm 6 1 2009 134 143
35. G. Lee, G. Kil, J. Kwon, S. Kim, J. Yoo, and J. Shin Oncostatin M as a target biological molecule of preeclampsia J Obstet Gynaecol Res 35 5 2009 869 875
36. I. Rioja, F.J. Hughes, C.H. Sharp, L.C. Warnock, D.S. Montgomery, and M. Akil Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor Arthritis Rheum 58 8 2008 2257 2267
37. E. Robak, A. Sysa-Jedrzejowska, H. Stepien, and T. Robak Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus Eur Cytokine Netw 8 3 1997 281 286 (Pubitemid 27470099)
38. A.R. Pradeep, T.M. S, G. Garima, and A. Raju Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease Biomarkers 15 3 2010 277 282
39. K. Koskela, T.T. Pelliniemi, K. Remes, A. Rajamaki, and K. Pulkki Serum oncostatin M in multiple myeloma: association with prognostic factors Br J Haematol 96 1 1997 158 160
40. M.T. Levy, M. Trojanowska, and A. Reuben Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cells J Hepatol 32 2 2000 218 226 (Pubitemid 30093900)
41. R.K. Verbeeck Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction Eur J Clin Pharmacol 64 12 2008 1147 1161
42. E. van de Steeg, E. Wagenaar, C.M. van der Kruijssen, J.E. Burggraaff, D.R. de Waart, and R.P. Elferink Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs J Clin Invest 120 8 2010 2942 2952
43. F. Takata, N. Sumi, T. Nishioku, E. Harada, T. Wakigawa, and H. Shuto Oncostatin M induces functional and structural impairment of blood-brain barriers comprised of rat brain capillary endothelial cells Neurosci Lett 441 2 2008 163 166
44. V.A. Luyckx, L.V. Cairo, C.A. Compston, W.L. Phan, and T.F. Mueller Oncostatin M pathway plays a major role in the renal acute phase response Am J Physiol Renal Physiol 296 4 2009 F875 F883